Skip to main content
AstraZenecaPartnership

AstraZeneca partners with Oracle for AI-driven clinical trials

Source: Autobound Signal API · 80 signals tracked for AstraZeneca · updated

Get AstraZeneca's live signals in Claude or ChatGPT, or by API

AskWhat changed at AstraZeneca this week? Use Autobound signals for astrazeneca.com.

What happened

AstraZeneca is partnering with UAE-based healthcare company M42 to support hypertension research in Abu Dhabi.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Estimated read time: Less than a minute Oct 20 - AstraZeneca said on Tuesday that it is ​working with Oracle to use AI and real-world data to identify eligible patients for ‌clinical trials and monitor safety signals, among other measures, as ⁠the drugmaker looks ​to improve clinical research. • ⁠The collaboration will combine AstraZeneca's drug development ‌expertise with Oracle's ‌AI and healthcare data capabilities to support ⁠patient matching and ⁠research • Initial work will focus on cancer, cardiovascular, respiratory, immunology and rare diseases, and could also support earlier diagnosis of serious diseases • The first project will support hypertension research ‌in Abu Dhabi in ​partnership with UAE-based healthcare firm M42 • Patient recruitment remains one of the biggest challenges in clinical research, with delayed enrolment often extending trial timelines and increasing development costs • Incorrect trial designs have also hurt AstraZeneca in ​the past, with delays on its breast cancer ‌drug and ‌nerve ⁠disorder treatment failure causing some worries • AstraZeneca is seeking to expand its medicine portfolio as it targets over $80 billion in annual revenue by ‌2030, and works to ​address industry bottlenecks in ‌drug development (Reporting by ⁠Atharva ​Singh and Pushkala Aripaka in Bengaluru; Editing by Priyanka ​G)

ksl.com/article/51638527/astrazeneca-partners-with-oracle-for-ai-driv...Read the full source

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

Location
Abu Dhabi, United Arab Emirates

Companies

  • M42Partnerm42.ae

The full record

From the Signal API record

Extraction

Confidence
85%
Detected
Oct 20, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for AstraZeneca and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AstraZeneca this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/0d9a3dbb-abf8-6a90-24f3-2883b3bcd875 returns this record as JSON. POST /v1/companies/enrich returns every signal for astrazeneca.com.

{
  "signal_id": "0d9a3dbb-abf8-6a90-24f3-2883b3bcd875",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-10-20T17:27:36+00:00",
  "company": {
    "name": "AstraZeneca",
    "domain": "astrazeneca.com"
  },
  "data": {
    "url": "https://www.ksl.com/article/51638527/astrazeneca-partners-with-oracle-for-ai-driven-clinical-trials",
    "title": "AstraZeneca partners with Oracle for AI-driven clinical trials - KSL News",
    "excerpt": "Estimated read time: Less than a minute Oct 20 - AstraZeneca said on Tuesday that it is ​working with Oracle to use AI and real-world data to identify eligible patients for ‌clinical trials and monitor safety signals, among other measures, as ⁠the drugmaker looks ​to improve clinical research. • ⁠The collaboration will combine AstraZeneca's drug development ‌expertise with Oracle's ‌AI and healthcare data capabilities to support ⁠patient matching and ⁠research • Initial work will focus on cancer, cardiovascular, respiratory, immunology and rare diseases, and could also support earlier diagnosis of serious diseases • The first project will support hypertension research ‌in Abu Dhabi in ​partnership with UAE-based healthcare firm M42 • Patient recruitment remains one of the biggest challenges in clinical research, with delayed enrolment often extending trial timelines and increasing development costs • Incorrect trial designs have also hurt AstraZeneca in ​the past, with delays on its breast cancer ‌drug and ‌nerve ⁠disorder treatment failure causing some worries • AstraZeneca is seeking to expand its medicine portfolio as it targets over $80 billion in annual revenue by ‌2030, and works to ​address industry bottlenecks in ‌drug development (Reporting by ⁠Atharva ​Singh and Pushkala Aripaka in Bengaluru; Editing by Priyanka ​G)",
    "summary": "AstraZeneca is partnering with UAE-based healthcare company M42 to support hypertension research in Abu Dhabi.",
    "location": "Abu Dhabi, United Arab Emirates",
    "planning": true,
    "image_url": "https://img.ksl.com/slc/3206/320610/32061081.JPG?filter=kslv2/responsive_story_lg",
    "confidence": 0.85,
    "published_at": "2026-10-20T17:27:36Z",
    "location_data": [
      {
        "city": "Abu Dhabi",
        "region": "Western Asia",
        "country": "United Arab Emirates",
        "continent": "Asia",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "The first project will support hypertension research ‌in Abu Dhabi in ​partnership with UAE-based healthcare firm M42",
    "related_company_name": "M42",
    "related_company_domain": "m42.ae"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.